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NREM: Non-rapid eye movement
T. gondii: Toxoplasma gondii
TNF: Tumor necrosis factor

Introduction
During infection, sleep and the immune system interact
to improve the fitness of the host by better allocation of
energy to critical physiological functions implicated in
controlling the infection [1]. While the majority of studies
focus on viral and bacterial infections, sleep is strongly
altered in parasitic infections too. For instance, in the
human African trypanosomiasis (sleeping sickness), there
is a complete loss of circadian rhythm with narcolepticlike fits and decreased total hours of wakefulness [2].
Moreover, changes in sleep duration have been associated
with parasitic infection in 12 mammalian species [3]. It
has been suggested that sleep “fuels” the immune system
to increase resistance to parasites [4]. Levels of cytokines
such as interleukin (IL)-1β, IL-10, IL-12 and tumor necrosis
factor (TNF) are at their highest during sleep, regardless
of circadian rhythms [1]. Proinflammatory cytokine
activity increases when a host is faced with an immune
challenge, which leads to increased duration of non-rapid
eye movement (NREM) sleep [4]. White blood cell counts
have also been associated with the total sleep time in 26
mammalian species [3].
Toxoplasma gondii (T. gondii) is a protozoan
parasite estimated to have infected 30% of the world’s
population [5]. Among Americans, the prevalence of T.
gondii seropositivity is approximately 13.2% [6]. It has
the ability to invade numerous warm-blooded animals
as intermediate hosts and members of the feline family,
who are its definitive hosts [7]. Within the cat, T. gondii
reproduces sexually and oocysts are formed and excreted
into the environment where they are ingested by rodents
and other intermediate hosts, including humans, through
contamination of food and water [8]. Consuming
contaminated undercooked meat also infects humans
[9-13]. The environment, the host’s genetic framework, the
specific strain of T. gondii, the parasitic stage and the route
of contamination during inoculation, all contribute to the
severity of T. gondii infection [14]. Many parasites [15],
including T. gondii [16, 17], have the capability to change the
behavior of their hosts to enhance the completion of their
life cycle. The immune system of an immunocompetent
host with chronic T. gondii infection contains the parasite
to its slow-growing forms inside tissue cysts [18-20].
There has been growing evidence that suggests increased
rates of T. gondii infection in individuals with mental

illness, in particular schizophrenia, including new-onset
schizophrenia [21, 22]. Sutterland et al. (2015) performed a
meta-analysis and uncovered significant associations of T.
gondii infection with schizophrenia, bipolar disorder and
obsessive-compulsive disorder [23]. Recently, we reported
that T. gondii IgG serointensity was positively associated
with cardinal symptoms of depression in the Old Order
Amish [24]. Links have also been identified between T.
gondii IgG seropositivity or serointensity and suicidal
behavior [25-29] and with an increased risk of traffic
accidents [30-32].
Disturbances in sleep are more common and severe
in those suffering from psychiatric conditions [33, 34],
including schizophrenia [35-39], depression [40], bipolar
disorder [41] and suicidal behavior [42-44], as well as car
accidents [45], all of which, as stated above, have also been
previously associated with T. gondii infection. We thus
reasoned that sleep impairment might mediate, at least in
part, the link between T. gondii infection and psychiatric
disorders and behavioral dysregulation. Recently, we
reported in a sample of Old Order Amish, no associations
of T. gondii IgG seropositivity and serointensity with
bedtime difficulties or daytime sleepiness [46].
Delayed sleep phase is associated with mood
disturbances, such as unipolar depression and bipolar
disorder [47]. Delayed timing and duration of sleep have
been reported in bipolar depression [48, 49]. Moreover,
severity of depressive symptoms is increased in those
with delayed timing of sleep [50]. Sleep midpoint has
also been reported to be delayed in those suffering from
depression [51]. Given these data, we expected that later
bedtime, mid-sleep time and wake-up time would be
positively associated with T. gondii IgG serointensity or
seropositivity.
Given that low-grade immune activation is known
to alter sleep [52], together with the production by T.
gondii of dopamine [53, 54], a wakefulness-promoting
neurotransmitter, we hypothesized that T. gondii would be
associated with changes in the duration of sleep, delayed
timing of sleep, problems maintaining sleep and increased
daytime problems due to poor sleep.

Methods
Study population
Data were drawn from the Amish Wellness Study, which
began in 2010 as part of a cardio-metabolic screening
program for the Amish community in Lancaster County,
Unauthenticated
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PA, USA. Amish Research Clinic of the University of
Maryland, Baltimore is located in Lancaster, PA, USA, and
nurses from this clinic recruited our study subjects. The
inclusion criteria included: belonging to the Old Order
Amish Community, being over 18 years old, and for our
sub-project − having responded to a variant of a sleep
questionnaire containing the variables of interest, as well
as having T. gondii IgG titers and seropositivity results
from a sub-study nested in the Amish Wellness Study that
focused on the environmental and genetic risk factors for
T. gondii infection. Informed consent for the parent Amish
Wellness study was obtained after a thorough explanation
of the study by nursing staff and Amish liaisons (Old Order
Amish women working to secure a culturally sensitive
interface between the Amish community and the nursing
and medical staff of the University of Maryland Baltimore
Amish Research Clinic). The protocol for the parent
Amish Wellness study was approved by the University of
Maryland, Baltimore Institutional Review Board.
The study sample comprised 833 Old Order Amish
adults [mean age (SD)=44.28 (16.99) years], which
included 341 (40.94%) men and 492 (59.06%) women.
They each responded to sleep questionnaires as part of a
wellness screen in Lancaster, PA. The questionnaires were
vetted by the Amish liaisons and by nursing personnel
familiar with the Amish participants and culture.
Fasting blood samples were centrifuged for 25
minutes at 400 g and at 4°C. Plasma was separated and
stored at -80°C. To determine T. gondii serologic status,
an enzyme-linked immunosorbent assay (ELISA) (IBL
International, Männedorf, Switzerland) was used to test
the plasma for IgG antibodies to T. gondii. The maximum
dilution was 1:20. Status of each of the samples (i.e.,
seropositive or seronegative for infection with T. gondii)
was defined by a predetermined cutoff value of 10 IU/mL,
with a mean coefficient of variation of 7%, as reported
by the ELISA manufacturer. When ELISA results indicated
an equivocal concentration of T. gondii IgG (8 to 12 IU/
mL), the test was repeated. If the level was under 8 IU/
mL or over 12 IU/mL, it was considered seronegative or
seropositive for infection with T. gondii, respectively.
The individuals with persistent equivocal results were
excluded from analysis.
Informed consent: Informed consent was obtained
from all individuals included in this study.
Ethical approval: The research related to human
use was in compliance with all the relevant national
regulations, institutional policies and in accordance with
the tenets of the Helsinki Declaration, and was approved
by the authors’ institutional review board or equivalent
committee.
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Sleep questionnaire
Selected questions were administered to measure
our variables of interest, which were all analyzed in
binary form. Sample sizes per variable differed due to
the availability of T. gondii serology results in those
subjects that had answered the sleep questionnaire. The
questions “trouble staying asleep” (sleep maintenance),
“problems during the day due to poor sleep” and
“daytime sleepiness” were answered by 833 individuals,
455 (54.62%) of which were T. gondii seropositive. Other
questions regarding sleep that did not include the ones
mentioned above (because of a change in questionnaire
length due to logistical issues), were previously analyzed
in relationship to markers of chronic T. gondii infection
[46]. Bedtime and wake-up time were self-reported and
the mid-sleep time was calculated. All sleep timings were
converted to decimal hours for analysis.

Statistical methods
The relationship between T. gondii IgG seropositivity and
transformed ranked answers from sleep questionnaires
were analyzed using binary logistic regression, adjusted
for age and sex (SAS version 9.3 SAS Institute Inc., Cary,
NC, USA). The associations of T. gondii IgG titers with sleep
duration and timing were analyzed using Linear Mixed
Models adjusted for age, sex and family aggregation, using
the Mixed Model Analysis for Pedigrees and Populations
(MMAP) [55].

Results
Digitally transformed timing of average bedtime (SD) was
21.38 (0.54), and average wake-up time (SD) was 05.14
(0.72). Average mid-sleep time (SD) was 01.26 (0.49). In
analog clock-time our participants’ average bedtime was
9:22 PM and wake-up time was 5:08 AM.

T. gondii seropositivity and sleep parameters
There were 455 (54.61%) T. gondii seropositive and 378
(45.39%) T. gondii seronegative participants. Sleep
variables in the overall sample and stratified by T. gondii
seropositivity status are presented in Table 1.
After adjustment for age and sex, T. gondii
seropositivity had a significant negative association with
difficulty staying asleep [OR 0.79, 95% CI: 0.68-0.92] and
Unauthenticated
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Table 1: Sleep parameters and T. gondii seropositive/seronegative status.
All

T. gondii (+)

T. gondii (-)

No

593 (71.53%)

330 (39.81%)

263 (31.72)

Yes

236 (28.47%)

122 (14.72%)

114 (13.75%)

No

415 (49.82%)

239 (28.69%)

176 (21.13%)

Yes

418 (50.18%)

216 (25.93%)

202 (24.25%)

Poor

13 (1.57%)

5 (0.60%)

8 (0.97%)

Good

815 (98.43%)

450 (54.35%)

365 (44.08%)

No

668 (80.19%)

381 (45.74%)

287 (34.45%)

Yes

165 (19.81%)

74 (8.88%)

91 (10.92%)

No

337 (40.46%)

199 (23.89%)

138 (16.57%)

Yes

496 (59.54%)

256 (30.73%)

240 (28.81%)

Sleep parameters
Trouble falling asleep (n = 829)

Trouble staying asleep (n = 833)

Sleep quality (n = 828)

Problems during the day due to poor sleep (n = 833)

Daytime sleepiness (n = 833)

problems during the day due to poor sleep [OR 0.77, 95%
CI: 0.64-0.92].

T. gondii serointensity and sleep parameters
T. gondii serointensity was significantly negatively
associated with bedtime and mid-sleep time, and
positively associated with sleep duration. Specifically,
higher T. gondii serointensity was associated with earlier
bedtime (β = -0.04, p = 0.0002), earlier mid-sleep time (β
= -0.002, p = 0.02) and longer sleep duration (β = 0.04,
p = 0.02). Wake-up time (β = -0.0009, p = 0.07) was not
significantly changed with T. gondii serointensity (trend
towards statistical significance).

Discussion
To our knowledge, the current study is the first to find
a significant association between markers of T. gondii
infection and sleep duration, timing and maintenance, as
well as problems during the day due to poor sleep. The
direction of these significant associations was, in part,
surprising. Earlier, rather than later, bedtime and midsleep time, and longer rather than shorter sleep duration,
were associated with higher T. gondii IgG titers. Moreover,

T. gondii IgG seropositive individuals reported less, rather
than more, difficulties in maintaining sleep and had fewer
problems during the day due to poor sleep.
One avenue by which T. gondii may influence sleep is
directly through its endogenous production of dopamine
[53, 54, 56]. Evidence indicates that there is a relationship
between dopamine and sleep-wake cycles. Patients with
Parkinson’s disease, which reduces dopamine-producing
neurons [57], often have excessive daytime sleepiness
[58]. Nishino et al. (1998) demonstrated that dopaminespecific reuptake blockers increase wakefulness in normal
and narcoleptic animals [59]. Wisor et al. (2001) reported
increased wakefulness and reduction in NREM sleep
in mice with the absence of the dopamine transporter
gene [60]. A study done on dopamine (D2) receptor
knockout mice showed decreased wakefulness, shorter
wake periods, increased NREM sleep and increased stage
transitions between being awake and NREM sleep [61].
Additionally in this study, sleep quality was also affected,
as indicated by the lower delta activity, a component of
deep sleep [61]. These data indicate the possibility that
dopamine promotes wakefulness.
Chronic infection with T. gondii may also promote
daytime wakefulness, as suggested by better self-reported
tolerance of daytime consequences of poor sleep in
our study sample. One way to explain the wakefulness
effect is by dopamine’s implication in homeostatic and
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circadian components of sleep/wake regulation, which
in turn are involved in numerous interactions with the
neural, endocrine and immunological systems. Dopamine
projects from the ventral tegmental area and substantia
nigra, both of which contain functional clocks that
schedule activities in a circadian manner [62-64], and
leads to the promotion of wakefulness [58, 59, 61]. T.
gondii can alter dopamine production in several ways.
Firstly, it possesses tyrosine hydroxylase [54], the ratelimiting enzyme in dopamine production [65]. Secondly,
inflammation secondary to T. gondii infection may
activate the kynurenine pathway, leading to decreased
brain levels of kynurenic acid, higher levels of which
have been reported to have an inverse relationship
with dopamine levels [66]. Thirdly, immune activation
(necessary to contain T. gondii in immunocompetent
hosts) may also interact with dopaminergic processes by
inducing alterations in the level of tyrosine, the precursor
of dopamine [65]. A high phenylalanine:tyrosine ratio,
resulting from inhibition of phenylalanine hydroxylase
[67, 68], can be the consequence of Th1 activation, one
of the central immune mechanisms responsible for
containing T. gondii infection in immunocompetent hosts
[69]. We recently reported how associations between T.
gondii and aggression [70] or impulsivity [71], known to
be in part modulated by dopaminergic pathways, interact
with plasma peripheral levels of phenylalanine:tyrosine
ratios.
Independent of dopaminergic mechanisms, as any
microbial organism, T. gondii can promote sleep through
the induction of the immune system. Immune pathways
that aid in the containment of T. gondii, as well as other
infections in the immunocompetent host, have also been
implicated in sleep-wake regulation. For instance, levels
of IL-12 and TNF, both proinflammatory cytokines that
have been linked to the acute control of T. gondii infection
[72-75], peak during sleep regardless of circadian factors
[1]. The activation of TNF initiates sleep [76]. IL-10,
an anti-inflammatory cytokine, prevents overly active
immune response during infection [77] and also peaks
during sleep [1]. It is possible that low-grade immune
activation, potentially as a direct consequence of T. gondii
infection, is involved in mediating the relationship of T.
gondii IgG seropositivity and IgG titers with sleep duration
and reduced problems in maintaining sleep. This could
be evaluated in future longitudinal studies with multiple
immune markers.
The evolutionary pull of survival may, in part, be
driving a parasite’s ability to protect sleep in its host
thereby benefitting both host and pathogen. The host
who sleeps longer with minimal nightly interruptions can

5

have better health and may be more equipped to contain
a pathogen through energy conservation [1, 3], ultimately
reducing the chance of death, other than via predation by
a representative of the cat family. Moreover, specifically
for T. gondii, increased activity and reduced neophobia
during wakefulness (as described in infected rodents)
[78], may increase chances of rodent predation by a feline,
thus completing the parasite’s life-cycle.
An alternative possibility is that some strains
of T. gondii act as microbial “Old Friends” with
immunoregulatory capabilities [79] and subsequently,
provide their intermediate host with a mutually beneficial
relationship, such as less problems related to sleep,
healthier timing and duration of sleep, with a greater
longevity of the host, as well as a longer exposure to
predation by the members of the cat family, eventually,
resulting in a greater chance for T. gondii to reproduce.
This would not be an isolated clinical link as it is known,
for example, that T. gondii infection is associated with
lower incidence of allergy and asthma [80, 81], conditions
that have also been linked to poor sleep [82, 83]. Although
T. gondii’s common route of infection in humans is through
the intestinal wall, there are relatively few studies focused
on chronic toxoplasmosis and long term consequences
on the gut microbiome, and further on immune function
studies in human or nonhuman animals. In one small
study, chronic T. gondii-infected mice did have an
increase in gut immunomodulatory bacteria compared to
uninfected mice [84].

Strengths of the study
The Amish have a relatively homogeneous lifestyle [85]
and have high rates of T. gondii seropositivity [86]. Limited
alcohol and substance use consumption, as well as the
absence of exposure to bright or blue artificial lighting
from television sets, cell phones and computers [85] that
alter the circadian rhythm and perturb sleep [87], are
additional strengths of our study.

Limitations
We had a cross-sectional design, did not adjust for
multiple comparisons (with only the negative association
between bedtime and T. gondii IgG serointensity being
able to resist a full adjustment for multiple comparisons,
post hoc), and used self-report sleep measures rather than
objective measures. Since, the study was done in the Old
Order Amish, the generalizability of the results is limited.
Unauthenticated
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We have not accounted for markers of inflammation and
have not analyzed IgM and other markers to differentiate
acute from chronic T. gondii infection. We cannot be sure if
the lack of a significant association of titers with wake-up
time is a result of more dominant environmental (likely
occupational demands) factors, in comparison to midsleep and bedtime, or it being a consequence of a type II
error due to a limited sample size, resulting in a statistical
trend rather than achieving statistical significance.
In sum, T. gondii IgG seropositivity is associated
with healthier sleep profiles, specifically having fewer
problems maintaining sleep and fewer daytime problems
due to poor sleep, and higher T. gondii IgG titers are
associated with earlier bedtime and mid-sleep time, and
longer sleep duration. Thus, there is no current evidence
to support deleterious associations between T. gondii
infection and sleep; hence, there are no grounds to
continue to expect that sleep impairment could mediate
the predictive associations between T. gondii infection and
mental illness, suicidal behavior, or traffic accidents. Our
results need to be replicated with longitudinal designs
using objective measures of sleep. Future studies should
also investigate potential immune mechanisms mediating
these associations by measuring a comprehensive panel
of inflammatory markers. For instance, given the high
seroprevalence of T. gondii and considerable rate of
seroconversion in the Amish, we can focus on measures of
sleep continuity and timing on actigraphic tracing, or even
polysomnography at baseline in T. gondii seronegative
individuals, and then compare sleep patterns and
differences from baseline in individuals who seroconverted
versus those who remained seronegative. At several
(at least two) time points, sleep questionnaires, sleep
latency, wake-maintenance tests, sleep onset and offset
and tests of alertness, such as the psychomotor vigilance
tests [88], could be related to T. gondii seropositive status,
serointensity, cytokine profiles and potential structural
and functional neuroimaging. Additionally, circadian
markers, such as dim light saliva melatonin onset [89,
90], could lead us closer to understanding the direction of
causality and mechanisms of the unexpected associations
revealed by our cross-sectional study.
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